SCHEMBL3144099

SCHEMBL3144099

CC(C)c1cc(O)ccc1C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.38
DPP4 P27487 1/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.37
PTGDR Q13258 1/20 0.37
HSP90AA1 P07900 3/20 0.36
HSP90AB1 P08238 3/20 0.36
NUDT1 P36639 1/20 0.36
BACE1 P56817 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
FAAH O00519 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
LMNA P02545 1/20 0.35
GABRA1 P14867 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
GABRB1 P18505 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20640289 0.84 TRPA1 (0.42) ANPEPDPP4HSP90AA1HSP90AB1NUDT1
SCHEMBL3813158 0.83 ESR2 (0.51) ESR1ESR2CYP3A4CYP2D6CYP2C9
SCHEMBL17398187 0.83 HTR2C (0.42) HTR2CCHRNB2CHRNA4
SCHEMBL28123258 0.79 KCNH2 (0.44) ANPEPDPP4CYP1A2CYP3A4BLM
SCHEMBL9005641 0.78 KMO (0.53) PTGDR2PTGDRMEN1ALDH1A1CYP2D6
SCHEMBL17699117 0.77 CHRNB2 (0.55) HSP90AA1HSP90AB1NUDT1BACE1ESR1
SCHEMBL3148621 0.77 PTGDR2 (0.47) PTGDR2HTR2CMEN1ALDH1A1CYP2D6
SCHEMBL3143517 0.77 OPRL1 (0.40) PTGDR2HSP90AA1HSP90AB1NUDT1BACE1
SCHEMBL27596780 0.76 ESR1 (0.38) PTGDR2ESR1ESR2
SCHEMBL70722 0.76 ALDH1A1 (0.46) HSP90AA1HSP90AB1NUDT1BACE1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137193-B1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI SA (FR) 2017-08-09 EP disclosed
CN-104447792-A Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI AVENTIS 2015-03-25 CN disclosed
US-8642603-B2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI (FR) 2014-02-04 US disclosed
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2010-03-25 US disclosed
CN-101675060-A Substituted dihydro and tetrahydro oxazolopyrimidinones, their preparation and use SANOFI AVENTIS 2010-03-17 CN disclosed
EP-2137193-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF Sanofi-Aventis (FR) 2009-12-30 EP disclosed
WO-2008112483-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF GRM2, GRM1, GRIN2C ANPEP 3983/4885DPP4 1533/4885PTGDR2 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.